WHO Issues Concern Over Severe Lack of Weight-Loss Injections
Less than one in 10 individuals who could benefit from obesity jabs such as Wegovy can access them, caution the global health agency as it issues its first guidance on the medications.
Given in excess of 1,000,000,000 individuals worldwide now living with obesity, it is calling for more widespread and fairer availability to this class of drugs.
According to projections, over two billion are projected to be living with obesity by 2030 unless action is taken.
"The new guidelines recognises that excess weight is a chronic disease that can be addressed with comprehensive and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and distribution challenges are significant obstacles to widespread access to the injections that can assist patients in reducing considerable body mass, notes the organization.
GLP-1 Therapy Supply Crisis
Even in the current best projected case, the supply of such drugs might only reach around 100 million people – fewer than 10% of those who need them, according to the health organization.
The advice urges nations and manufacturers to increase access, through approaches such as voluntary licensing.
A patent on semaglutide – the core ingredient of the drug Wegovy – is scheduled to end in multiple nations in 2026.
The Way Weight-Loss Drugs Operate
These medications imitate a body's own hormone to reduce digestion speed, reduce hunger and increase feelings of fullness so individuals reduce food intake.
People usually begin shedding pounds within a few weeks of beginning the regular doses.
Research points to people may regain a significant portion a year later of discontinuing the medication, because their normal food cravings resume.
To be above a healthy weight increases your chance for contracting health problems, such as type 2 diabetes, cardiovascular issues, brain attack, and specific malignancies.
Obesity concerns people in every country and was associated with over three and a half million deaths worldwide in 2024, as per the health agency.
